I also refer my colleagues to the following news articles and documents: ``Australian Drug Maker has Low Profile but Powerful Backers in Washington,'' printed in the New York Times on January 13 of this year; ``Aussie shareholding puts heat on President's Ally,'' published in the Australian on February 6 of this year; the 2016 Annual Report to Shareholders of Innate; a periodic transaction report that Congressman Price filed with the House Ethics Committee on September 12, 2016; a list of the 20 largest investors in Innate dated January 17, 2017; and a stock price history of Innate. I wish to turn to the issue of misleading testimony. What remains unresolved are major inconsistencies between Congressman Price's testimony to the Finance Committee, statements by Congressman Collins, and statements by Innate's CEO Simon Wilkinson published last week in the Wall Street Journal. Simply put, Innate's chief executive and Congressman Collins, the company's top shareholder, provided one version of events to one of the world's most respected newspapers. Congressman Price provided a different version of events to the Finance Committee and the Health committee. These inconsistencies are among the reasons that Democrats boycotted last week's Finance Committee markup. The Senate has an obligation to know the truth about these transactions in order to protect the integrity of this body and its constitutional duty to consider executive branch nominees.…
Share
More from Ron Wyden
Oregon’s Coast Guard works tirelessly every day to keep our coastal communities and fishermen safe, and they deserve the same tools as the rest of our military branches to operate efficiently.
Oregon’s public universities produce top-tier scientific breakthroughs, and lab discoveries shouldn't sit on a shelf when they could be creating good-paying jobs and growing our local economy.
This bill gives him so much discretion that Trump can ultimately decide what countries to tariff, or what countries to exempt. And he can modify tariffs at his will.
We urge the State Department to ensure timely processing of F, M, and J student and exchange visitor nonimmigrant visas, consistent with the approach taken by administrations of both parties in the past, and to implement other measures to…





